5 Broker-Adored Stocks to Watch as Iran-U.S. Tensions Refuse to Fade
CNC, ADM, AVT, ARW and AMN emerge from a broker-focused screen as Iran-U.S. tensions, rising oil prices and rate uncertainty cloud markets.
CNC, ADM, AVT, ARW and AMN emerge from a broker-focused screen as Iran-U.S. tensions, rising oil prices and rate uncertainty cloud markets.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AMN Healthcare's 2026 surge is backed by rebounding nurse and allied demand, stronger execution and persistent healthcare workforce shortages.
AMN Healthcare is rated BUY, driven by robust nurse staffing demand and strong YTD share price performance (+110%). AMN trades at a compelling 5.2x forward EV/EBITDA, a 59% discount to the sector and 32% below its five-year average. Secular nurse shortages, AI-driven operational efficiencies, and improving margins underpin AMN's positive outlook and earnings momentum.
Weak July jobs data dims September rate-hike odds, putting broker-favored stocks like Avnet, RXO, Forward Air, Air Canada and AMN Healthcare in focus.
Dimensional Fund Advisors LP trimmed its position in shares of AMN Healthcare Services Inc (NYSE: AMN) by 5.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 741,209 shares of the company's stock after selling 44,529 shares during the period. Dimensional Fund
AMN Healthcare Services NYSE: AMN reported second-quarter results above its guidance range, aided by stronger demand in travel nursing, allied staffing and search services, as well as labor disruption-related revenue and several favorable reserve items.
AMN Healthcare's Q2 EPS jumps 158% as revenues rise 2.3%, helped by travel nurse, allied and search growth plus labor disruption activity.
AMN Healthcare Services, Inc. (AMN) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.77 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.3 per share a year ago.
Quarterly revenue of $673 million and adjusted EBITDA of $73 million; GAAP income of $0.53/share and adjusted EPS of $0.77 DALLAS, Aug. 6, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2026 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.
Arrowstreet Capital Limited Partnership grew its holdings in shares of AMN Healthcare Services Inc (NYSE: AMN) by 1,278.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,401,725 shares of the company's stock after purchasing an additional 1,300,005 shares
PENN, CSV, GM and AMN emerge as late-2026 value picks, supported by attractive valuations, earnings growth and cash-flow strength.
Investors interested in Business - Services stocks are likely familiar with AMN Healthcare Services (AMN) and Rentokil Initial PLC (RTO). But which of these two stocks presents investors with the better value opportunity right now?
Here is how AMN Healthcare Services (AMN) and Dave Inc. (DAVE) have performed compared to their sector so far this year.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DALLAS, July 21, 2026 (GLOBE NEWSWIRE) -- As demand for orthodontic care continues to rise—valued at approximately $22 billion in 2025 and projected to reach $26.9 billion by 2030—and Smile Doctors expands its national footprint, the organization today announced the appointment of Jeff Knudson as chief financial officer. An accomplished healthcare and multisite finance executive, Knudson will lead the company's financial strategy and finance organization.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.